CD8A and COVID-19: The counts of CD3+ T cell, CD4+ T cell, and CD8+ T cell remarkably increased to the normal level, indicating the reversal of lymphopenia, which is a common feature of the COVID-19 patients and associated with disease severity and mortality.[4] Therefore, inhibition of inflammation and modulation of immune system by MSC are possibly effective on the treatment of COVID-19 patient.